Ongoing An
Internal Medicine
2023-09-20

Ongoing Antihypertensive Therapy Associated With Decreased Dementia Risk in Late-Life

By Denise Baez , DG News Among older adults with hypertension, use of antihypertensive medication was associated with decreased dementia risk compared with individuals with untreated hypertension through all ages in late life, and those on antihypertensive therapy had no increased risk of dementia compared with healthy controls, according to a study published in JAMA Network Open. "In this individual participant data meta-analysis with data from 16 countries, we found that hypertension was a risk factor associated with dementia in late life," wrote Matthew J. Lennon, MD, University of Ne...

Internal Medicine
2023-09-18

Cardiovascular efficacy and safety of antidiabetic agents: A network meta-analysis of randomize...

AIM An important characteristic of glucose-lowering therapies (GLTs) is their ability to prevent cardiovascular complications. We aimed to investigate the cardiorenal efficacy and general safety of GLTs. MATERIALS AND METHODS Multicentre, ra

Internal Medicine
2023-09-15

Beta Blockers Linked to Lower Risk of Total Knee Replacement in Patients With Osteoarthritis

Among patients with knee pain, those who take beta-blockers appear to have a lower risk of total knee arthroplasty (TKA) for the treatment of advanced osteoarthritis (OA), according to a study published in The Journal of Bone & Joint Surgery. "Our...

Videos from category: Cardiology

Heart Fail
2:32

Heart Failure management in the post-COVID era - Lessons from the pandemic

ESC 2023
Key points
7:23

Key points from the 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

ESC 2023
Prospectiv
2:40

Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19

ESC 2023
Burden of
6:17

Burden of Cardiovascular Disease in the European Union

ESC 2023

Videos from category: Diabetology

Targeting
9:22

Targeting CV risk factors with GLP-1 RAs in people with obesity

EASD 2022
Once weekl
7:36

Once weekly insulin: The ONWARDS 2 study

EASD 2022
Is HFpEF h
20:42

Is HFpEF hiding in your practice? Key messages of the DELIVER study: Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

EASD 2022
Semaglutid
10:59

Semaglutide 2.4 mg reduces the 10-year type 2 diabetes risk in people with overweight or obesity

EASD 2022

Videos from category: Hematology

LMWH use i
6:49

LMWH use in pregnancy: The Highlow and the ALPINE trial

ASH 2022
Novelties
12:44

Novelties in the treatment of multiple myeloma 2021

ASH 2021
Novelties
8:35

Novelties in the treatment of myelofibrosis and polycythemia vera 2021

ASH 2021
Risks for
5:01

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology

ASH 2021

Videos from category: Internal Medicine

The Journe
3:15

The Journey to Address Unmet Needs Across all Haemophilia Indications

ISTH 2022
Anticoagul
8:47

Anticoagulant Advancements for VTE in Children

ISTH 2022
Clinical C
6:18

Clinical Challenges in Patients with Venous Thromboembolism

ISTH 2022
Good pract
19:37

Good practice statements for antithrombotic therapy in the management of COVID-19

ISTH 2022

Videos from category: Oncology

HER2 treat
12:07

HER2 treatment landscape 2023

ESMO Breast Cancer 2023
What's new
8:09

What's new in treatment of breast cancer? - Highlights of ESMO BC 2023

ESMO Breast Cancer 2023
Hot topics
15:11

Hot topics in melanoma management

EADO 2023
Functional
10:33

Functional Precision Medicine in Oncology

AACR 2023

Videos from category: Psychiatry

Current is
13:39

Current issues in the treatment of schizophrenia

EPA 2023
Highlights
10:47

Highlights of EPA 2023

EPA 2023
Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021

Videos from category: Respiratory

Choices in
10:06

Choices in asthma and COPD care: How to maximize outcomes for patients

ERS 2022
The digita
11:38

The digital age: The future of respiratory medicine

ERS 2021
Pulmonary
7:05

Pulmonary hypertension and interstitial pulmonary fibrosis

ERS 2021
ERS/EAACI
8:50

ERS/EAACI statement on adherence to international adult asthma guidelines

ERS 2021

Sixty Seconds Science

0:54
Do overweight and obesity confer an additional risk of CAD in patients with FH?
1:17
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
1:17
The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA
1:15
The issue of adjuvant vs neoadjuvant treatment
1:19
The treatment sequence in metastatic melanoma
1:12
LMWH use in pregnancy: The ALPINE trial
1:19
Functional Precision Medicine in Oncology
1:10
The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator
1:18
Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease

Spotify episodes

Apple podcasts

Google podcasts

Search by Scientific Content
Search by Congress
Search:
Date
Filters:
Key points
7:23
Title Description

Key points from the 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Presenter: Marco Metra
Cardiology
ESC 2023
Heart Fail
2:32
Title Description

Heart Failure management in the post-COVID era - Lessons from the pandemic

Presenter: Theresa McDonagh
Cardiology
ESC 2023
Highlights
9:50
Title Description

Highlights of ESC2023 Congress - Heart failure in focus

Presenter: Carlos Aguiar
Cardiology
ESC 2023
Burden of
6:17
Title Description

Burden of Cardiovascular Disease in the European Union

Presenter: Panos Vardas
Cardiology
ESC 2023
Prospectiv
2:40
Title Description

Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19

Presenter: Mikhail Kosiborod
Cardiology
ESC 2023
When real-
8:47
Title Description

When real-world data meet real patients' needs: how to optimally treat patients with chronic coronary syndromes in 2023?

Presenter: Luis Henrique Gowdak
Cardiology
ESC 2023
STEP HFpEF
3:20
Title Description

STEP HFpEF: once-weekly semaglutide in people with HFpEF and obesity

Presenter: Mikhail Kosiborod
Cardiology
ESC 2023
Main headl
6:52
Title Description

Main headlines of 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Presenter: Theresa McDonagh
Cardiology
ESC 2023
2023 ESC G
4:36
Title Description

2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes - from the cardiologist's perspective

Presenter: Nikolaus Marx
Cardiology
ESC 2023
HEART-FID:
5:40
Title Description

HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency

Presenter: Robert Mentz
Cardiology
ESC 2023
DICTATE-AH
6:08
Title Description

DICTATE-AHF: Early Dapagliflozin Initiation in Acute Heart Failure

Cardiology
ESC 2023
2023 ESC G
5:28
Title Description

2023 ESC Guidelines for the Management of Endocarditis

Presenter: Michael A. Borger
Cardiology
ESC 2023
OCT vs. IV
4:34
Title Description

OCT vs. IVUS vs. angiography guidance: a real-time updated network meta-analysis

Presenter: Gregg Stone
Cardiology
ESC 2023
2023 ESC G
7:51
Title Description

2023 ESC Guidelines for the Management of Cardiomyopathies

Presenter: Juan Pablo Kaski
Cardiology
ESC 2023
2023 ESC G
6:54
Title Description

2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes - from the diabetologist's perspective

Presenter: Massimo Federici
Cardiology
ESC 2023
2023 ESC G
11:14
Title Description

2023 ESC Guidelines for the Management of Acute Coronary Syndromes

Presenter: Borja Ibanez
Cardiology
ESC 2023

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease: Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology
Do overwei
0:54
Title Description

Do overweight and obesity confer an additional risk of CAD in patients with FH?

Presenter: Amany Elshorbagy
Cardiology
Interrupti
1:17
Title Description

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Presenter: Matteo Lambertini
Oncology
The Omega-
1:17
Title Description

The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA

Presenter: Eliot A. Brinton
Cardiology
The issue
1:15
Title Description

The issue of adjuvant vs neoadjuvant treatment

Presenter: Paolo A. Ascierto
Oncology
The treatm
1:19
Title Description

The treatment sequence in metastatic melanoma

Presenter: Paolo A. Ascierto
Oncology
LMWH use i
1:12
Title Description

LMWH use in pregnancy: The ALPINE trial

Presenter: Saskia Middeldorp
Hematology
Functional
1:19
Title Description

Functional Precision Medicine in Oncology

Presenter: Anthony Letai
Oncology
The first
1:10
Title Description

The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator

Presenter: Jeffrey Weber
Oncology
Elevated L
1:18
Title Description

Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease

Presenter: Nathan D. Wong
Cardiology
Long-term
8:46
Title Description

Long-term efficacy and safety of ixekizumab

Presenter: Andrew Blauvelt
Dermatology
Paradigm s
12:05
Title Description

Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment

Presenter: Federico Cappuzzo
Oncology
How will t
9:43
Title Description

How will the current therapeutic options change the treatment of RCC in the daily practice?

Presenter: Camillo Porta
Oncology
The role o
5:58
Title Description

The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma

Presenter: David F. McDermott
Oncology
Treatment
11:50
Title Description

Treatment intensification in the treatment of prostate cancer

Presenter: Oliver Sartor
Oncology
Pembrolizu
16:35
Title Description

Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma

Presenter: Stefan N. Symeonides
Oncology
State of t
6:13
Title Description

State of the art treatment of bladder cancer

Presenter: Matthew R. Zibelman
Oncology